Litcius/Paper detail

Double setback for ASO trials in Huntington disease

Katie Kingwell

2021Nature Reviews Drug Discovery116 citationsDOI

Topics & Concepts

HuntingtinHuntington's diseaseSetbackPipeline (software)DiseaseHuntingtin ProteinClinical trialAntisense therapyMedicineComputational biologyIntensive care medicineBioinformaticsComputer scienceBiologyPolitical scienceInternal medicineGeneticsGeneOligonucleotideLawLocked nucleic acidProgramming languageBiotechnology and Related FieldsGenetic Neurodegenerative DiseasesCRISPR and Genetic Engineering
Double setback for ASO trials in Huntington disease | Litcius